Summit Trail Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
2,271
+616
| +37% | +$323K | 0.02% | 410 |
|
|
2025
Q1 | $1.05M | Buy |
1,655
+259
| +19% | +$164K | 0.03% | 150 |
|
|
2024
Q4 | $994K | Buy |
1,396
+6
| +0.4% | +$4.27K | 0.04% | 140 |
|
|
2024
Q3 | $1.46M | Buy |
1,390
+133
| +11% | +$140K | 0.04% | 206 |
|
|
2024
Q2 | $1.32M | Buy |
1,257
+108
| +9% | +$114K | 0.03% | 193 |
|
|
2024
Q1 | $1.11M | Buy |
1,149
+111
| +11% | +$107K | 0.03% | 205 |
|
|
2023
Q4 | $912K | Sell |
1,038
-64
| -6% | -$56.2K | 0.03% | 193 |
|
|
2023
Q3 | $907K | Buy |
1,102
+38
| +4% | +$31.3K | 0.03% | 181 |
|
|
2023
Q2 | $765K | Buy |
1,064
+244
| +30% | +$175K | 0.03% | 196 |
|
|
2023
Q1 | $674K | Buy |
820
+157
| +24% | +$129K | 0.03% | 180 |
|
|
2022
Q4 | $478K | Buy |
663
+22
| +3% | +$15.9K | 0.02% | 193 |
|
|
2022
Q3 | $442K | Sell |
641
-247
| -28% | -$170K | 0.02% | 198 |
|
|
2022
Q2 | $525K | Buy |
888
+32
| +4% | +$18.9K | 0.03% | 175 |
|
|
2022
Q1 | $598K | Buy |
+856
| New | +$598K | 0.05% | 144 |
|
|
2018
Q3 | – | Sell |
-329
| Closed | -$114K | – | 414 |
|
|
2018
Q2 | $114K | Buy |
+329
| New | +$114K | 0.04% | 195 |
|
|
2018
Q1 | – | Sell |
-721
| Closed | -$275K | – | 1371 |
|
|
2017
Q4 | $275K | Buy |
+721
| New | +$275K | 0.03% | 342 |
|